Mankind Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,469.60
-106.3 (-4.13%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 24.74 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
41.28
41.26
40.06
40.06
40.06
40.06
Share Warrants & Outstandings
Total Reserve
16,211.34
14,247.46
9,299.78
7,395.10
6,115.17
4,681.94
Shareholder's Funds
16,300.34
14,332.39
9,363.09
7,435.22
6,155.23
4,722.00
Minority Interest
260.71
235.79
212.70
188.07
161.08
0.00
Long-Term Borrowings
2,821.23
5,526.19
24.87
23.15
49.19
57.67
Secured Loans
2,518.98
5,088.86
24.87
23.15
48.94
57.42
Unsecured Loans
302.25
437.33
0.00
0.00
0.25
0.25
Deferred Tax Assets / Liabilities
1,515.28
1,704.62
8.68
47.54
16.33
-35.98
Other Long Term Liabilities
101.37
34.03
30.67
30.67
23.14
13.4
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
248.65
155.06
123.12
97.89
80.00
72.24
Total Non-Current Liabilities
4,686.53
7,419.90
187.34
199.24
168.68
107.33
Current Liabilities
Trade Payables
1,341.33
1,133.40
777.06
1,008.18
1,076.40
666.97
Other Current Liabilities
969.07
909.45
744.19
407.84
463.73
275.36
Short Term Borrowings
3,383.11
2,956.84
171.17
139.49
818.83
176.86
Short Term Provisions
813.74
663.87
427.31
307.63
264.50
234.22
Total Current Liabilities
6,507.25
5,663.56
2,119.73
1,863.14
2,623.46
1,353.40
Total Liabilities
27,754.83
27,651.64
11,882.86
9,685.67
9,108.45
6,323.62
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
21,089.14
20,723.51
5,775.71
5,108.36
4,172.90
2,102.27
Less: Accumulated Depreciation
2,714.74
1,886.28
1,354.82
977.44
657.49
497.69
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
18,374.40
18,837.23
4,420.89
4,130.92
3,515.41
1,604.58
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
654.78
306.13
207.10
493.19
669.87
371.62
Intangible assets under development
472.85
519.54
74.70
56.95
31.60
0.33
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
447.92
351.14
315.13
276.32
240.43
211.30
Long Term Loans & Advances
554.72
293.08
163.97
187.54
163.88
145.25
Other Non Current Assets
49.91
189.00
13.79
98.51
13.09
29.53
Total Non-Current Assets
20,800.63
20,663.37
5,314.64
5,357.80
4,701.63
2,416.98
Current Assets Loans & Advances
Current Investments
1,537.31
1,690.84
2,258.11
1,075.47
874.46
1,306.17
Inventories
2,144.48
2,093.71
1,553.46
1,498.46
1,760.24
1,183.54
Sundry Debtors
1,729.51
1,538.34
848.28
576.42
388.17
330.61
Cash and Bank
482.77
554.50
708.10
453.20
405.94
700.74
Other Current Assets
103.43
100.12
106.80
68.15
173.62
109.78
Short Term Loans and Advances
956.70
1,010.76
1,093.47
660.27
804.39
275.79
Total Current Assets
6,954.20
6,988.27
6,568.22
4,327.87
4,406.82
3,906.64
Net Current Assets (Including Current Investments)
446.95
1,324.71
4,448.49
2,464.74
1,783.35
2,553.24
Total Current Assets Excluding Current Investments
5,416.89
5,297.43
4,310.11
3,252.40
3,532.36
2,600.46
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
27,754.83
27,651.64
11,882.86
9,685.67
9,108.45
6,323.62
Contingent Liabilities
1,139.03
1,043.73
119.23
55.54
87.21
28.70
Total Debt
6,204.34
8,483.03
196.04
162.64
868.03
234.53
Book Value per share (adjusted)
16301.46
347.37
233.73
185.61
153.65
117.88
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is -26.86% vs 4,227.19% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 197.88% vs 10.96% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is -0.60% vs 313.64% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 27.56% vs 11.43% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is -0.49% vs 6.40% in Mar 2025

Compare Balance Sheet Results of Mankind Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
41.28
100.60
-59.32
-58.97%
Share Warrants & Outstandings
Total Reserve
16,211.34
27,010.80
-10,799.46
-39.98%
Shareholder's Funds
16,300.34
27,111.40
-10,811.06
-39.88%
Minority Interest
260.71
2,470.80
-2,210.09
-89.45%
Long-Term Borrowings
2,821.23
3,188.00
-366.77
-11.50%
Secured Loans
2,518.98
6.50
2,512.48
38,653.54%
Unsecured Loans
302.25
3,181.50
-2,879.25
-90.50%
Deferred Tax Assets / Liabilities
1,515.28
-374.60
1,889.88
504.51%
Other Long Term Liabilities
101.37
1,745.20
-1,643.83
-94.19%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
248.65
445.30
-196.65
-44.16%
Total Non-Current Liabilities
4,686.53
5,003.90
-317.37
-6.34%
Current Liabilities
Trade Payables
1,341.33
2,845.10
-1,503.77
-52.85%
Other Current Liabilities
969.07
3,806.80
-2,837.73
-74.54%
Short Term Borrowings
3,383.11
8,581.50
-5,198.39
-60.58%
Short Term Provisions
813.74
478.50
335.24
70.06%
Total Current Liabilities
6,507.25
15,711.90
-9,204.65
-58.58%
Total Liabilities
27,754.83
50,298.00
-22,543.17
-44.82%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
21,089.14
34,309.80
-13,220.66
-38.53%
Less: Accumulated Depreciation
2,714.74
10,204.00
-7,489.26
-73.40%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18,374.40
24,105.80
-5,731.40
-23.78%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
654.78
1,165.70
-510.92
-43.83%
Intangible assets under development
472.85
2,532.80
-2,059.95
-81.33%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
447.92
1,764.10
-1,316.18
-74.61%
Long Term Loans & Advances
554.72
781.50
-226.78
-29.02%
Other Non Current Assets
49.91
42.00
7.91
18.83%
Total Non-Current Assets
20,800.63
30,391.90
-9,591.27
-31.56%
Current Assets Loans & Advances
Current Investments
1,537.31
5,775.80
-4,238.49
-73.38%
Inventories
2,144.48
5,628.10
-3,483.62
-61.90%
Sundry Debtors
1,729.51
5,415.70
-3,686.19
-68.06%
Cash and Bank
482.77
1,416.60
-933.83
-65.92%
Other Current Assets
103.43
648.40
-544.97
-84.05%
Short Term Loans and Advances
956.70
1,021.50
-64.80
-6.34%
Total Current Assets
6,954.20
19,906.10
-12,951.90
-65.06%
Net Current Assets (Including Current Investments)
446.95
4,194.20
-3,747.25
-89.34%
Total Current Assets Excluding Current Investments
5,416.89
14,130.30
-8,713.41
-61.66%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
27,754.83
50,298.00
-22,543.17
-44.82%
Contingent Liabilities
1,139.03
989.90
149.13
15.07%
Total Debt
6,204.34
11,769.50
-5,565.16
-47.28%
Book Value per share (adjusted)
16,301.46
269.50
16,031.96
5,948.78%
Annual - Borrowings
Borrowings 6,204.34 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -26.86% vs 4,227.19% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 101.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 197.88% vs 10.96% in Mar 2025

Annual - Fixed Assets
Fixed Assets 19,029.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.60% vs 313.64% in Mar 2025

Annual - Investments
Investments 447.92 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.56% vs 11.43% in Mar 2025

Annual - Current Assets
Current Assets 6,954.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.49% vs 6.40% in Mar 2025